Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Gambaryan, F. Perros, A. Lombet, M. Mazmanian, M. Humbert (Clamart, France). The CXCL12/SDF-1, CXCR4, CXCR7 axis in experimental hypoxic pulmonary hypertension. Eur Respir J 2009; 34: Suppl. 53, 1587

Member's Comments

No comment yet.

Related content which might interest you: A role for the CXCL12 receptor, CXCR7, in the pathogenesis of human pulmonary vascular disease Source: Eur Respir J 2012; 39: 1415-1424 Year: 2012 Expression of angiogenic growth factors and stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis in idiopathic pulmonary fibrosis: a lung tissue study Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008 Fractalkine and its receptor (CX3CR1) in primary pulmonary hypertension (PPH) Source: Eur Respir J 2001; 18: Suppl. 33, 2s Year: 2001 CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis Source: Eur Respir J 2009; 34: 676 Year: 2009 Targeting CCR2 and CCR5 to inhibit macrophage/pulmonary artery smooth muscle cells cross-talk in pulmonary hypertension Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 The effects of AMD3100, a CXCR4 antagonist, on the bleomycin-induced pulmonary fibrosis Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 Ang-1/BMPR2 signaling and the expressions of MCP-1 and ICAM in over circulation-induced experimental pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 533s Year: 2004 Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21 Source: Eur Respir J 2007; 29: 1082-1093 Year: 2007 T-helper cell type-1 transcription factor T-bet is upregulated in pulmonary sarcoidosis Source: Eur Respir J 2011; 38: 1136-1144 Year: 2011 Differential expression of stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis between idiopathic pulmonary fibrosis and interstitial pneumonia associated with collagen vascular disease: a bronchoalveolar la Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation Source: Eur Respir J 2008; 31: 783-789 Year: 2008 Endothelin-a receptor antagonists reduce eNOS gene expression in rats with chronic hypoxic pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 271s Year: 2003 RAGE-dependent VCAM-1 expression in the pulmonary endothelium mediates IL-33 induced asthma pathogenesis Source: International Congress 2017 – Therapeutic approaches in lung disease Year: 2017 TrkB expression is altered in hypoxia-induced pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 606s Year: 2007 The role of chemokine receptors in acute lung allograft rejection Source: Eur Respir J 2010; 35: 167-175 Year: 2010 Neutralization of CXCL12 reverses established pulmonary hypertension in the sugen-hypoxia rat model Source: International Congress 2017 – Experimental PH Year: 2017 Hypoxia-induced increase in NO production and eNOS expression by murine pulmonary microvascular endothelial cells Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling Year: 2006 Role of anti-proliferative therapy in PAH Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008 Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension Source: Eur Respir J 2016; 48: 1137-1149 Year: 2016 The interleukin 13 receptor system is altered in pulmonary arterial hypertension Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling Year: 2006